Warfarin sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for warfarin sodium and what is the scope of freedom to operate?
Warfarin sodium
is the generic ingredient in five branded drugs marketed by Bristol Myers Squibb, Pharm Res Assoc, Upsher Smith Labs, Abbott, Amneal Pharms, Aurobindo Pharma Usa, Barr, Chartwell Rx, Invagen Pharms, Ipca Labs Ltd, Pliva, Taro, Usl Pharma, Watson Labs, and Zydus Pharms Usa, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.There are twenty drug master file entries for warfarin sodium. Twenty-five suppliers are listed for this compound.
Summary for warfarin sodium
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 15 |
NDAs: | 21 |
Drug Master File Entries: | 20 |
Finished Product Suppliers / Packagers: | 25 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 38 |
Patent Applications: | 6,575 |
Drug Prices: | Drug price trends for warfarin sodium |
Drug Sales Revenues: | Drug sales revenues for warfarin sodium |
What excipients (inactive ingredients) are in warfarin sodium? | warfarin sodium excipients list |
DailyMed Link: | warfarin sodium at DailyMed |
Recent Clinical Trials for warfarin sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Amgen | Early Phase 1 |
Boehringer Ingelheim | N/A |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
Pharmacology for warfarin sodium
Drug Class | Vitamin K Antagonist |
Mechanism of Action | Vitamin K Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for warfarin sodium
US Patents and Regulatory Information for warfarin sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | COUMADIN | warfarin sodium | TABLET;ORAL | 009218-025 | Nov 18, 1996 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ipca Labs Ltd | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 200104-002 | Jun 27, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma Usa | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040415-005 | Sep 27, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pliva | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040616-006 | Jul 5, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Aurobindo Pharma Usa | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040415-004 | Sep 27, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040145-009 | Nov 5, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.